Citius Oncology CTOR
NASDAQ CTOR
$0.95 -0.03 (-3.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026)

Updated

Citius Oncology's Interest & Investment Income came in at $96,848 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 121.5% from the prior quarter.

Analysis

Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Citius Oncology's Interest & Investment Income was $36,373.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Citius Oncology 100.47 Mn 100.47 Mn 1.00 Mn 96,848.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96,848.00
Mar 31, 2026 43,721.00
Dec 31, 2025 28,288.00
API Access

Citius Oncology Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CTOR&period=max&api_key=YOUR_API_KEY